NCT03583489View on ClinicalTrials.gov

Study of APD421 With and Without Ondansetron

PHASE1CompletedINTERVENTIONAL

Enrollment

30

Participants

Timeline

Start Date

July 17, 2018

Primary Completion Date

August 13, 2018

Study Completion Date

August 13, 2018

Conditions

Postoperative Nausea and Vomiting

Interventions

DRUG

APD421

10 mg IV

DRUG

Placebo

IV

DRUG

Ondansetron

4 mg IV

Trial Locations (1)

Unknown

Early Phase Clinical Unit, London

Sponsors

Lead Sponsor

Acacia Pharma Ltd

All Listed Sponsors

lead

Acacia Pharma Ltd

INDUSTRY